Nexavar significantly boosts hypertension risk: study
634482
Bayer AG and Onyx Pharmaceutical Inc.'s key cancer drug Nexavar significantly raises the risk of high blood pressure, U.S. researchers said on Tuesday.
304307
Pfizer Inc. on Friday said two small  clinical trials showed heart bypass surgery patients taking  Bextra, an anti-inflammatory in the same class as the recently  withdrawn drug Vioxx, had a higher risk of stroke and heart  attack.
738848
Lumiracoxib, developed by Novartis AG under the trade name Prexige, is a COX-2 inhibitor analgesic drug that has significantly better effects on blood pressure than the older generic drug ibuprofen, researchers said on Friday.
709067
NEW YORK  - In patients with rheumatoid   arthritis, use of disease-modifying antirheumatic drugs, or   DMARDs, seems to lower the increased risk of cardiovascular   disease associated with rheumatoid arthritis, research   suggests.
424951
NEW YORK - A new round of trials have shown a boosted risk of heart problems among patients taking the painkiller Celebrex, manufacturer Pfizer Inc.
51255
The diabetes drug Actos cuts the risk of heart attack, stroke and death, but raises the risk of heart failure, according to one study published on Tuesday, while a second confirmed disputed findings that rival Avandia raises heart risks.
665144
More evidence of how painkillers called COX-2 inhibitors can raise the risk of heart disease was published Monday, showing Pfizer Inc.'s Bextra can triple the risk of heart attack and stroke in certain patients.
393322
MONDAY, Oct. 11 (HealthDayNews) -- The breast cancer drug tamoxifen may cause a slight increase in stroke risk, says a Duke University Medical Center study in the Oct. 12 issue of Neurology.
182394
The popular pain relief drug Celebrex can triple the risk of heart attacks and strokes, according to a study by the US National Cancer Institute.
16585
The blood-thinning drug Angiomax works as well as rival drugs, but with 47 percent less risk of major bleeding, to maintain blood flow in patients who have had a heart attack or severe chest pain, according to study results published on Wednesday.
248966
NEW YORK  - Tadalafil may increase the  blood pressure-lowering effects of doxazosin, which is commonly  prescribed for the treatment of enlarged prostate, or benign  prostatic hyperplasia (BPH), researchers report in the Journal  of Neurology.
242032
Some patients who are new users of antidepressants such as Paxil and Prozac and other selective serotonin reuptake inhibitors may run a risk of abnormal bleeding, researchers said on Monday.
479491
Drugmaker Pfizer said Friday that its Bextra drug, seen as an alternative to Merck&#39;s Vioxx arthritis medication, may raise heart risk in high-risk bypass surgery patients.
208400
A late-stage trial of Nexavar in patients with nonsmall-cell lung cancer after a committee said it would not meet the main goal of improving overall survival.
359602
Rasilez, the first of a new class of   hypertension drugs developed by Novartis, produces a consistent   and sustained reduction in blood pressure over a full year of   treatment, researchers said on Sunday.
220260
CHICAGO  - A common hypertension medication appears to dramatically reduce the risk of complications or death in patients with heart disease, but without the high blood pressure that often goes hand-in-hand with the condition, a study said.
259606
German drugmaker Bayer  plans to file this year for market approval for Nexavar to treat liver cancer after a study showed the drug significantly prolongs life for patients in the advanced stages of the disease.